Skip to main content
S&P 5007,670.84-0.17%DOW51,349.92-0.26%NASDAQ26,797.54-0.09%GOLD$4,210.50+0.74%OIL$89.25-0.15%
Delayed
Smart Investors Daily
CA

NASDAQ · CAMP

CAMP4 Therapeutics Corporation

Healthcare · Biotechnology

$3.85

Up+$0.06 (+1.56%)

Updated Sep 30, 2026, 12:57 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
125.74M
P/E ratio
-2.24
Dividend yield
0.00%
52-week range
$2.90 – $7.75
Volume
116.91K
Avg. volume
166.84K

Price performance · CAMP

CAMP price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Sep 28, 2026

CAMP closed at $3.85 after 19 trading sessions, up 1.58% for the selected period.

Last close
$3.85
Period change
+1.58%
Period low
$3.72
Period high
$4.49
Daily close
View OHLC price history
CAMP OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 28, 2026$3.86$3.95$3.73$3.85116.91K
Sep 25, 2026$3.83$4.06$3.724$3.92477.4K
Sep 24, 2026$3.78$3.94$3.675$3.84130.35K
Sep 23, 2026$4.13$4.27$3.65$3.72192.93K
Sep 22, 2026$4.21$4.24$3.86$4.15161.17K
Sep 21, 2026$4.27$4.32$4.10$4.17289.48K
Sep 18, 2026$4.03$4.27$3.945$4.241.04M
Sep 17, 2026$3.96$4.25$3.93$4.0393.44K
Sep 16, 2026$4.19$4.37$3.84$3.86300.79K
Sep 15, 2026$4.23$4.275$4.03$4.19175.27K
Sep 14, 2026$4.26$4.49$4.18$4.25167.04K
Sep 11, 2026$4.46$4.54$4.21$4.25101.15K
Sep 10, 2026$4.30$4.495$4.145$4.34115.64K
Sep 9, 2026$4.45$4.50$4.33$4.3379.92K
Sep 8, 2026$4.40$4.53$4.30$4.40280.48K
Sep 4, 2026$4.45$4.64$4.331$4.41131.12K
Sep 3, 2026$3.87$4.53$3.76$4.491.28M
Sep 2, 2026$3.85$4.0695$3.78$3.80215.2K
Sep 1, 2026$3.85$3.95$3.70$3.79229.39K

Latest CAMP news

The latest Smart Investors Daily articles mentioning CAMP.

Stock researchCompany · Overview

Company

OverviewForecastEarnings — requires Earnings Calls and Results accessDividend — requires Dividend Research accessFinancials

Market Activity

OptionsInsider Trades — requires Insider Buying and Selling accessShort InterestInstitutional Ownership — requires Institutional Ownership accessSentiment

CAMP research

Overview

Company profile and research snapshot.

Company profile

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$7.00
Implied upside
—
Analysts
12
CAMP recent ratings
DateFirmRatingTarget
Aug 14, 2026Piper SandlerOverweight—
Jun 16, 2026JP MorganOverweight—
Jun 10, 2026Chardan CapitalBuy—
Apr 14, 2026Rodman & RenshawBuy—
Apr 2, 2026Leerink PartnersOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 10, 2026

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

Authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) builds on CAMP4’s recent clearances to initiate first-in-human studies for CMP-002 in Australia and Argentina Company anticipates initiation of the clinical trial in 4Q 2026 WATERTOWN, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics design

Yahoo · Sep 8, 2026

CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026

WATERTOWN, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, will host a virtual Analyst Day on Monday, September 28, 2026 from 12:00 – 1:30 PM ET featuring presentations and Q&A led by CAMP4’s executive leadersh

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By